Improved Facial Skin Quality After VYC-12L for Breast Cancer Survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study examines the effects of intradermal VYC-12L injections on facial skin quality among breast cancer survivors. Eligible participants are adults who completed chemotherapy or monoclonal antibody therapy within the past 1–18 months. The study aims to document changes in skin appearance and related quality of life using questionnaires and clinical assessments. No randomized assignment or control group is described. Safety monitoring focuses on known risks of dermal hyaluronic acid products.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients over 18 years old of age.
* Patients with a previous clinical history of having had breast cancer, who have received treatment and finished with chemotherapy and/or systemic monoclonal antibodies between the previous 1-18 months.
* Patients who have received and completed treatment with neoadjuvant or adjuvant chemotherapy and/or monoclonal antibodies to breast cancer surgery between 1-18 months prior to recruitment.
* Patients who, in the physician's opinion, can understand and properly answer study questionnaires.
* Patients to whom participation in this study was offered and they voluntarily decided to join and signed the informed consent.

Exclusion Criteria:

* Patients suffering from untreated epilepsy.
* Patients with a tendency to develop hypertrophic scars.
* Patients with known hypersensitivity to hyaluronic acid and/or gram-positive bacterial proteins since hyaluronic acid is produced by Streptococcus type bacteria.
* Patients with known hypersensitivity to lidocaine or amide-type local anesthetics.
* Patients suffering from porphyria.
* Pregnant or lactating women.
* Patients presenting inflammatory and/or infectious processes (acne, herpes, etc.).
* Patients should not be subjected to laser treatments, deep chemical peels or dermabrasion during the duration of the study.
* Patients with no history of psychiatric illnesses derived from the oncologic diagnosis such as confirmed major depression.

Where it's running

• Ctra.Madrid-Cartagena, s/n, El Palmar
  Murcia, Murcia, Spain Recruiting

Study contacts

• Study coordinator: Antonio J Lozano, Doctor
• Email: antoniojlozano@live.com
• Phone: ES 626980234

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Nipple reconstruction with cross-linked hyaluronic acid after mastectomy

  This trial will test whether adding a cross-linked hyaluronic acid injection to areola micropigmentation helps women who had a mastectomy achieve better nipple projection, appearance, and satisfaction.

  Recruiting Germans Trias i Pujol Hospital · Badalona, Barcelona · NCT07008339

• Ultraformer MPT with Fractional CO2 vs Fractional CO2 Alone for Facial Rejuvenation

  This pilot test compares whether adding micro-focused ultrasound to fractional CO2 laser treatment improves facial rejuvenation in women aged 50–65.

  Recruiting Clinique Face MD · Montreal, Quebec · NCT07896512

• MD60000: a gel filler for aging-related skin imperfections

  This study tests whether the MD60000 gel filler safely improves facial wrinkles in adults with aging-related skin changes.

  Recruiting Promoitalia Group Spa · Torre del Greco, Napoli · NCT07873112

• Breast cancer subtypes and outcomes in Colombian women

  This study looks back at medical records of women with breast cancer to see how different molecular subtypes relate to survival and recurrence in a single Colombian hospital.

  Recruiting Fundación Santa Fe de Bogota · Bogotá, Bogota D.C. · NCT07856225

• Multimodal psychosomatic symptom care for breast cancer: personalized acupuncture care guided by shared decision-making

  This study tests whether personalized acupuncture options (manual acupuncture, ear acupuncture, or both) can help women with breast cancer who have anxiety, sleep problems, or fatigue, compared to routine nursing care.

  Recruiting at 3 sites First Teaching Hospital of Tianjin University of Traditional Chinese Medicine · Tianjin and 2 other locations · NCT07763587

• Slow Jogging for Breast Cancer Survivors

  This study tests whether a 12-week slow jogging program helps sleep quality in women who have completed breast cancer treatment.

  Recruiting Mackay Memorial Hospital · Taipei, Taipei City · NCT07757763

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.